Previous | Next
Part: 12 Session: 145678910111213141516171819202122 Page 861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930 of 999
has got leucocyte and fibroblast clones, and they think: “What's the use of going through all that? Let's get something they don't have.” So there's a race between them and Hoffman-LaRoche on immune interferon, because immune is said in animals in mice and in test tubes to potentiate leucocyte interferon. So if it potentiates it, it may mean that you don't need to have all those different clones separated out.
It would be a short-cut.
Yes, it might be a short-cut. We don't know.
You told me last year that Schering was at the point of cloning the leucocytes, and they were about to give some to Dr. Gutterman.
Well, they had some, but Hoffman-LaRoche did clone and they did give it to them last February. So Schering has clones from Weisman -- you know, this man in Zurich who made the first clone.
And got all the publicity.
Yes.
But they didn't have the great scientific backup that Roche, Genentech, have, and so they had to farm out some of the work, and it just wasn't
© 2006 Columbia University Libraries | Oral History Research Office | Rights and Permissions | Help